share_log

Aslan Pharmaceuticals | 424B4: Prospectus

SEC announcement ·  May 8, 2018 06:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more